<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2">Human metapneumovirus (hMPV), which was first isolated from children with respiratory tract infections (RTIs) in the Netherlands in 2001 and belongs to the Paramyxoviridae family and Pneumovirus subfamily
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>, is a leading cause of respiratory infections in children worldwide
 <sup>
  <xref ref-type="bibr" rid="CR2">2</xref>,
  <xref ref-type="bibr" rid="CR3">3</xref>
 </sup>. hMPV has been recognized as a causative agent of respiratory infections, including upper respiratory infections, severe bronchiolitis and pneumonia, in all age groups, with more severe disease occurring in infants, elderly people, and immunocompromised hosts
 <sup>
  <xref ref-type="bibr" rid="CR4">4</xref>â€“
  <xref ref-type="bibr" rid="CR7">7</xref>
 </sup>. The epidemic season of hMPV is reported to occur from winter to early spring
 <sup>
  <xref ref-type="bibr" rid="CR8">8</xref>
 </sup>. There are no effective vaccines or drugs to combat hMPV infection.
</p>
